Related Experiment Videos
Pediatric bupropion-induced serum sicknesslike reaction
1Clinical Psychiatry, New York University Medical School, New York, NY 10017, USA. Sabine.Hack@med.nyu.edu
Journal of Child and Adolescent Psychopharmacology
|January 15, 2005
Summary
This report details two pediatric cases of serum sickness-like reactions to bupropion, a rare but serious adverse drug event. Early recognition and discontinuation of bupropion are crucial for managing this immune-complex reaction in children.
Area of Science:
- Pediatric Pharmacology
- Adverse Drug Reactions
- Immunology
Background:
- Serum sickness-like reactions (SSLRs) are immune-complex mediated diseases characterized by fever, lymphadenopathy, arthralgias, and urticaria.
- Bupropion is an antidepressant with known adverse drug reactions, including seizures.
- SSLRs are typically self-limiting upon removal of the offending antigen.
Observation:
- Two pediatric cases (ages 12 and 14) of SSLRs following bupropion use are reported.
- The incidence of SSLRs to bupropion may be underrecognized compared to other adverse events like seizures.
- Symptoms of SSLRs are painful, temporarily disfiguring, and disabling, necessitating prompt medical evaluation.
Findings:
- Bupropion can induce SSLRs in pediatric patients.
- SSLRs to bupropion, while potentially rare or underreported, present with classic symptoms of fever, rash, and joint pain.
- Discontinuation of bupropion is the primary treatment for bupropion-induced SSLRs.
Implications:
- Healthcare providers should consider SSLRs in children presenting with symptoms consistent with this reaction after bupropion initiation.
- Educating parents and young patients about potential bupropion side effects, including SSLRs, is essential for early detection and management.
- Further research is needed to determine the prevalence and risk factors for bupropion-induced SSLRs in pediatric populations.